Cardiovascular preventive role of thiazolidinedione in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention [0.03%]
噻唑烷二酮在2型糖尿病经皮冠状动脉介入治疗患者中的心血管预防作用
Jinkwon Kim,Jimin Jeon,Joonsang Yoo et al.
Jinkwon Kim et al.
Background: Thiazolidinediones (TZD) are a class of oral antidiabetic medications that improve glycemic control and insulin sensitivity. We evaluated the cardiovascular outcomes according to thiazolidinedione (TZD) use in...
Bridging gaps in diabetic neuropathy care: A Delphi-based regional consensus from the Gulf Cooperation Council [0.03%]
利用德尔菲法达成的海湾合作委员会地区关于糖尿病神经病变护理共识
Abdulrahman Alshaikh,Abdulnabi T Alattar,Ahmed Abdul Karim Hassoun et al.
Abdulrahman Alshaikh et al.
Aims/introduction: Diabetic peripheral neuropathy (DPN) is a common complication of diabetes in the Gulf Cooperation Council (GCC) region, associated with delayed diagnosis, significant pain burden, and preventable compli...
Association of BCAAs/BCKAs with pancreatic steatosis in patients with type 2 diabetes mellitus: A cross-sectional study [0.03%]
糖尿病患者支链氨基酸与胰腺脂肪变性的横断面研究
Jie Gao,Pijun Cheng,Fusong Jiang et al.
Jie Gao et al.
Aims: To examine the association between branched-chain α-keto acids (BCKAs) and pancreatic steatosis in patients with type 2 diabetes (T2DM). Methods: ...
Effects of esaxerenone add-on therapy versus angiotensin II receptor blocker dose escalation on albuminuria and blood pressure in hypertensive patients with type 2 diabetes: An exploratory randomized study [0.03%]
盐皮质激素受体拮抗剂esorasartan与血管紧张素II受体拮抗剂治疗2型糖尿病肾病患者的降蛋白尿及降压疗效的探索性研究：一项随机对照研究
Makoto Ohara,Takemasa Omachi,Nobuaki Takehana et al.
Makoto Ohara et al.
Aims: Residual albuminuria remains a major clinical challenge in patients with type 2 diabetes mellitus and hypertension despite renin-angiotensin system inhibitor therapy. Esaxerenone, a selective nonsteroidal mineraloco...
Serum-derived microribonucleic acids as potential novel biomarkers for slowly progressive type 1 diabetes mellitus [0.03%]
Ⅰ型成人晚发糖尿病患者血清微小核糖核酸谱系分析及潜在标志物筛查
Hideyuki Okuma,Takahiro Tsutsumi,Masashi Ichijo et al.
Hideyuki Okuma et al.
Objectives: We aimed to identify microribonucleic acids (miRNAs) that could serve as biomarkers for slowly progressive type 1 diabetes mellitus (SPIDDM). ...
Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis [0.03%]
利拉鲁肽通过重新编程血管平滑肌细胞代谢来抑制糖尿病动脉粥样硬化中外源性基质重塑
Kun Zhu,Hanxiu Liu,Ni He et al.
Kun Zhu et al.
Background: Metabolic reprogramming contributes to vascular dysfunction in diabetic atherosclerosis, but the mechanisms linking hyperglycemia-induced metabolic alterations to extracellular matrix remodeling in vascular sm...
Real-world risk factors and clinical implications of early estimated glomerular filtration rate decline after sodium-glucose cotransporter-2 inhibitor therapy [0.03%]
钠葡萄糖协同转运蛋白-2抑制剂治疗后早期估算肾小球滤过率下降的现实世界风险因素和临床意义
Jangwook Lee,Dayoung Kang,Kyoung-Ah Kim et al.
Jangwook Lee et al.
Aim: To assess the prevalence, risk factors, estimated glomerular filtration rate trajectory, and clinical implications of the early estimated glomerular filtration rate dip after sodium-glucose cotransporter 2 inhibitors...
Takafumi Ojima,Toshimasa Yamauchi
Takafumi Ojima
Recent genomic studies in Asian populations have advanced our understanding of the diagnosis, pathophysiology, risk prediction, and precision care of diabetes. Monogenic diabetes, including maturity-onset diabetes of the young (MODY) and mi...
Alteration of subgingival microbiome in patients with type 2 diabetes induced by diabetes treatment [0.03%]
二甲双胍和吡格列酮对2型糖尿病患者牙周下面微生物群的影响
Moe Inoue,Akito Sakanaka,Naoto Katakami et al.
Moe Inoue et al.
Aims/introduction: Diabetes and periodontal disease, a bacterial infection involving the oral microbiome, have a bidirectional relationship. However, the relationship between poor glycemic control and the oral microbiome ...